Alignment Healthcare (NASDAQ:ALHC) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Alignment Healthcare (NASDAQ:ALHC) announced its earnings results on Thursday. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.24) by ($0.01), Briefing.com reports. The business had revenue of $628.60 million for the quarter, compared to the consensus estimate of $599.75 million. Alignment Healthcare had a negative net margin of 8.12% and a negative return on equity of 75.64%. The firm’s revenue for the quarter was up 43.1% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.20) EPS.

Alignment Healthcare Stock Up 26.0 %

ALHC traded up $1.37 during mid-day trading on Friday, reaching $6.63. 3,023,068 shares of the stock were exchanged, compared to its average volume of 898,686. Alignment Healthcare has a 1 year low of $4.46 and a 1 year high of $9.20. The company has a debt-to-equity ratio of 1.02, a quick ratio of 1.84 and a current ratio of 1.84. The stock has a market capitalization of $1.26 billion, a PE ratio of -8.39 and a beta of 1.23. The company has a 50 day moving average price of $5.11 and a two-hundred day moving average price of $6.55.

Insider Activity

In other Alignment Healthcare news, insider Dawn Christine Maroney sold 23,000 shares of Alignment Healthcare stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $5.44, for a total transaction of $125,120.00. Following the transaction, the insider now owns 1,830,008 shares of the company’s stock, valued at approximately $9,955,243.52. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, CFO Robert Thomas Freeman sold 11,858 shares of the stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $4.89, for a total transaction of $57,985.62. Following the completion of the transaction, the chief financial officer now owns 898,228 shares in the company, valued at $4,392,334.92. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Dawn Christine Maroney sold 23,000 shares of Alignment Healthcare stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $5.44, for a total transaction of $125,120.00. Following the completion of the sale, the insider now directly owns 1,830,008 shares in the company, valued at approximately $9,955,243.52. The disclosure for this sale can be found here. Insiders sold a total of 90,213 shares of company stock worth $460,587 over the last quarter. Insiders own 6.30% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on ALHC shares. Barclays assumed coverage on shares of Alignment Healthcare in a research note on Wednesday, March 6th. They set an “underweight” rating and a $4.50 target price on the stock. Piper Sandler restated a “neutral” rating and issued a $6.00 target price (down from $12.00) on shares of Alignment Healthcare in a research note on Wednesday, March 6th. UBS Group dropped their price target on Alignment Healthcare from $9.00 to $8.50 and set a “neutral” rating on the stock in a research note on Wednesday, February 28th. Stephens raised their price objective on Alignment Healthcare from $6.00 to $7.00 and gave the company an “equal weight” rating in a research note on Friday. Finally, William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a research report on Wednesday, March 6th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $8.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.